212 related articles for article (PubMed ID: 32344757)
1. Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
Geissler K; Jäger E; Barna A; Gurbisz M; Graf T; Graf E; Nösslinger T; Pfeilstöcker M; Tüchler H; Sliwa T; Keil F; Geissler C; Heibl S; Thaler J; Machherndl-Spandl S; Zach O; Weltermann A; Bettelheim P; Stauder R; Zebisch A; Sill H; Schwarzinger I; Schneeweiss B; Öhler L; Ulsperger E; Kusec R; Germing U; Sperr WR; Knöbl P; Jäger U; Hörmann G; Valent P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344757
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia.
Geissler K; Jäger E; Barna A; Gurbisz M; Graf T; Graf E; Nösslinger T; Pfeilstöcker M; Machherndl-Spandl S; Stauder R; Zebisch A; Sill H; Öhler L; Kusec R; Hörmann G; Valent P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842710
[TBL] [Abstract][Full Text] [Related]
3. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
4. Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival.
Geissler K; Jäger E; Barna A; Graf T; Graf E; Öhler L; Hoermann G; Valent P
Eur J Haematol; 2021 May; 106(5):627-633. PubMed ID: 33432601
[TBL] [Abstract][Full Text] [Related]
5. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
[TBL] [Abstract][Full Text] [Related]
6. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
7. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
[TBL] [Abstract][Full Text] [Related]
8. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
Kuo MC; Liang DC; Huang CF; Shih YS; Wu JH; Lin TL; Shih LY
Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830
[TBL] [Abstract][Full Text] [Related]
9. Chronic myelomonocytic leukemia: myeloproliferative variant.
Onida F; Beran M
Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
[TBL] [Abstract][Full Text] [Related]
10. BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS.
Zhang L; Singh RR; Patel KP; Stingo F; Routbort M; You MJ; Miranda RN; Garcia-Manero G; Kantarjian HM; Medeiros LJ; Luthra R; Khoury JD
Am J Hematol; 2014 May; 89(5):499-504. PubMed ID: 24446311
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice.
Parikh C; Subrahmanyam R; Ren R
Blood; 2006 Oct; 108(7):2349-57. PubMed ID: 16763213
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells.
Geissler K; Ohler L; Födinger M; Virgolini I; Leimer M; Kabrna E; Kollars M; Skoupy S; Bohle B; Rogy M; Lechner K
J Exp Med; 1996 Oct; 184(4):1377-84. PubMed ID: 8879210
[TBL] [Abstract][Full Text] [Related]
13. High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.
Tyner JW; Erickson H; Deininger MW; Willis SG; Eide CA; Levine RL; Heinrich MC; Gattermann N; Gilliland DG; Druker BJ; Loriaux MM
Blood; 2009 Feb; 113(8):1749-55. PubMed ID: 19075190
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of β Common Receptor Moderately Attenuates the Progression of Myeloproliferative Neoplasm in NrasG12D/+ Mice.
Zhang J; Ranheim EA; Du J; Liu Y; Wang J; Kong G; Zhang J
J Biol Chem; 2015 Jul; 290(31):19093-103. PubMed ID: 26082490
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.
Patnaik MM; Tefferi A
Blood Cancer J; 2016 Feb; 6(2):e393. PubMed ID: 26849014
[TBL] [Abstract][Full Text] [Related]
17. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia.
Montalban-Bravo G; Kanagal-Shamanna R; Li Z; Hammond D; Chien K; Rodriguez-Sevilla JJ; Sasaki K; Jabbour E; DiNardo C; Takahashi K; Short N; Issa GC; Pemmaraju N; Kadia T; Ravandi F; Daver N; Borthakur G; Loghavi S; Pierce S; Bueso-Ramos C; Kantarjian H; Garcia-Manero G
Br J Haematol; 2023 Nov; 203(4):581-592. PubMed ID: 37608562
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.
Kohlmann A; Grossmann V; Klein HU; Schindela S; Weiss T; Kazak B; Dicker F; Schnittger S; Dugas M; Kern W; Haferlach C; Haferlach T
J Clin Oncol; 2010 Aug; 28(24):3858-65. PubMed ID: 20644105
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
Carr RM; Patnaik MM
Curr Opin Hematol; 2020 Jan; 27(1):2-10. PubMed ID: 31688455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
